Reneo Pharmaceuticals Stock Quote RPHM - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.51

Bid

1.49

Ask

1.51

Volume

2,220

1.48 Day's Range 1.52

0.9801 52 Week Range 9.21

Market Cap

50.465M

Previous Close

1.50

Open

1.48

Last Trade

1.5

Last Trade Time

13:32:12

Financial Volume

$ 3,352

VWAP

1.5097

Average Volume (3m)

284,065

Shares Outstanding

33,420,808

Dividend Yield

PE Ratio

-0.65

Earnings Per Share (EPS)

-2.32

Revenue

Net Profit

-77.39M

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

reneopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was $1.50. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of $ 0.9801 to $ 9.21.

Reneo Pharmaceuticals currently has 33,420,808 shares outstanding. The market capitalization of Reneo Pharmaceuticals is $50.13 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.65.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-0.657894736842	1.52	1.5351	1.47	45120	1.48743958	CS
4	-0.08	-5.03144654088	1.59	1.65	1.46	179063	1.51291513	CS
12	-0.15	-9.03614457831	1.66	1.93	1.42	284065	1.6124843	CS
26	-0.07	-4.43037974684	1.58	1.93	1.42	243736	1.63343885	CS
52	-5.16	-77.3613193403	6.67	9.21	0.9801	420210	2.49019837	CS
156	-7.43	-83.1096196868	8.94	11.3999	0.9801	186495	3.32457163	CS
260	-13.79	-90.1307189542	15.3	16.83	0.9801	178190	3.7044301	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.77k
RGCRegencell Bioscience Holdings Ltd	$ 26.54 (687.54%)	534.42k
SLRXSalarius Pharmaceuticals Inc	$ 4.1101 (166.89%)	54.35M
ATPCAgape ATP Corporation	$ 0.225 (57.34%)	97.01M
SPWRSunPower Corporation	$ 1.125 (57.17%)	152.6M
FLYEFly E Group Inc	$ 1.25 (-80.41%)	13.96M
RNAZTransCode Therapeutics Inc	$ 0.30 (-62.15%)	7.82M
JAGXJaguar Health Inc	$ 1.8417 (-56.87%)	13.9M
MIRAMIRA Pharmaceuticals Inc	$ 2.472 (-50.66%)	23.2M
SLNASelina Hospitality PLC	$ 0.0249 (-32.70%)	119.96M
ADILAdial Pharmaceuticals Inc	$ 1.405 (32.55%)	154.83M
SPWRSunPower Corporation	$ 1.125 (57.17%)	152.6M
SLNASelina Hospitality PLC	$ 0.0249 (-32.70%)	119.96M
NVDANVIDIA Corporation	$ 122.73 (-0.66%)	115.38M
ATPCAgape ATP Corporation	$ 0.225 (57.34%)	97.01M